Chapter 19. Alcohol Septal Ablation in the Treatment of Hypertrophic Obstructive Cardiomyopathy: A Seven-Year Experience

  1. Barry J. Maron MD
  1. Horst Kuhn MD,
  2. Thorsten Lawrenz MD,
  3. Frank Lieder MD,
  4. Frank H. Gietzen MD,
  5. Ludger Obergassel MD,
  6. Claudia Strunk-Muller MD,
  7. Berit Stolle MD and
  8. Christian H. Leuner MD

Published Online: 25 OCT 2007

DOI: 10.1002/9780470987469.ch19

Diagnosis and Management of Hypertrophic Cardiomyopathy

Diagnosis and Management of Hypertrophic Cardiomyopathy

How to Cite

Kuhn, H., Lawrenz, T., Lieder, F., Gietzen, F. H., Obergassel, L., Strunk-Muller, C., Stolle, B. and Leuner, C. H. (2004) Alcohol Septal Ablation in the Treatment of Hypertrophic Obstructive Cardiomyopathy: A Seven-Year Experience, in Diagnosis and Management of Hypertrophic Cardiomyopathy (ed B. J. Maron), Blackwell Publishing, Malden, Massachusetts, USA. doi: 10.1002/9780470987469.ch19

Editor Information

  1. Director, The Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, Minneapolis, Minnesota

Publication History

  1. Published Online: 25 OCT 2007
  2. Published Print: 27 FEB 2004

ISBN Information

Print ISBN: 9781405117326

Online ISBN: 9780470987469

SEARCH

Keywords:

  • hypertrophic obstructive cardiomyopathy;
  • transcoronary ablation of septal hypertrophy;
  • non-surgical septal reduction therapy;
  • percutaneous septal myocardial ablation;
  • alcohol septal ablation

Summary

This chapter contains sections titled:

  • Technique

  • Indications

  • Subjective outcome and objective measurements

  • Complications

  • Prognosis and limitations

  • Comparison with surgical and dual-chamber pacing treatment

  • Conclusions